Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
ID: 355354Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for the Change of Recipient Organization, allowing current NIH grant holders to request a transfer of their grant to a new recipient organization. This opportunity is specifically designed for organizations holding certain types of NIH grants, enabling them to maintain the integrity of their research while facilitating institutional changes that align with programmatic goals. Eligible applicants include a wide range of entities such as higher education institutions, nonprofits, and tribal governments, with applications subject to NIH Grants Policy Statement requirements. Interested parties should submit their applications by July 12, 2027, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PA-24-254.html for further details.

    Point(s) of Contact
    Files
    Title
    Posted
    The National Institutes of Health (NIH) has released a Notice of Funding Opportunity (NOFO) for applications regarding the Change of Recipient Organization for specific NIH grant types. This funding opportunity allows current organizations holding NIH grants to request a change in their recipient organization while ensuring that the proposed research remains within the scope of the original grant. Applications for multi-project and complex codes must be submitted on paper, whereas single-project applications can be submitted electronically. Key details include the requirement for all applications to adhere to the NIH Grants Policy Statement, where prior approval from the Grants Management Specialist is necessary. The eligibility for applicants spans various entities, including higher education institutions, nonprofits, and local governments. Additionally, various NIH Institutes and Centers are involved, and co-funding may occur through certain offices. The submission process emphasizes strict adherence to guidelines, with specific attention required for proposed research involving human subjects or animals. Ultimately, NIH aims to support the continuum of health research by facilitating institutional changes that align with programmatic goals while maintaining regulatory compliance and research integrity.
    Similar Opportunities
    Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for organizations holding specific types of NIH grants to submit applications for changes in recipient organization status, known as Successor-in-Interest. This initiative aims to facilitate transitions for organizations while ensuring project continuity, allowing eligible applicants—including various higher education institutions, nonprofits, government entities, and foreign organizations—to propose research that aligns with the original NIH-supported project scope. Applications will undergo an administrative evaluation focusing on compliance with federal regulations, with key dates including an open submission period starting July 19, 2024, and a funding expiration date set for July 18, 2027. Interested parties can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for competing revisions to existing Single Project Research Grants and Cooperative Agreements, with the option for clinical trials. This initiative allows NIH award recipients to apply for additional funds to expand their current projects within the relevant Institutes and Centers, specifically in response to Notices of Special Interest (NOSI) issued by participating NIH entities. The funding opportunity, identified as PA-23-317, is open to a wide range of eligible applicants, including higher education institutions, nonprofit organizations, and foreign entities, reflecting NIH's commitment to advancing impactful health research. Applications must be submitted by November 24, 2026, through the NIH ASSIST system or Grants.gov, and will be evaluated based on scientific merit and adherence to specified criteria. For further information, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) to support discrete scientific projects aligned with the interests of various NIH Institutes and Centers. This grant is specifically designed for projects that do not involve clinical trials, focusing instead on advancing health-related research and development. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and tribal governments, with no fixed budget limits, although applicants must justify their requested funding. Interested parties should note that the application deadline is January 7, 2025, and can find more information by contacting the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV or visiting the official announcement at http://grants.nih.gov/grants/guide/pa-files/PA-20-185.html.
    Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) titled "Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies," aimed at enhancing research infrastructure to support interdisciplinary projects in aging science. This funding opportunity encourages the development of novel research partnerships and seeks applications that demonstrate significant advancements in research infrastructure, with a focus on biomedical, social, and behavioral research related to aging mechanisms. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and government entities, with a funding cap of $500,000 per year for projects lasting up to five years. Interested parties can find more information and submit applications through Grants.gov, with a submission deadline of December 2, 2025. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced an urgent funding opportunity for competitive revisions to existing research grants aimed at addressing immediate public health crises. This initiative allows Principal Investigators holding specific NIH grants to apply for additional funding to meet unforeseen needs related to public health emergencies, with applications routed directly to the relevant NIH awarding component. The program emphasizes support for diverse institutions, including historically underrepresented entities, and aims to enhance research capacity in critical health areas. Interested applicants can find more details and submit inquiries via grantsinfo@nih.gov, with proposals due by October 25, 2025, under the funding opportunity announcement PA-23-044.
    Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced an Emergency Competitive Revision program aimed at providing funding for applications related to disasters declared under the Stafford Act or public health emergencies. This initiative is designed to support existing NIH awards and facilitate projects that address urgent public health issues stemming from such emergencies. Eligible applicants include a diverse range of organizations, such as higher education institutions, nonprofits, and local governments, particularly those impacted by recent disasters. The funding opportunity, designated as PA-24-201, opens on April 19, 2024, with applications due by April 18, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PA-24-201.html.
    Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for the Focused Technology Research and Development (R01 Clinical Trial Not Allowed) grant, aimed at supporting innovative technology projects that advance biomedical research. Eligible applicants include a diverse range of institutions, such as Historically Black Colleges and Universities, Tribal Colleges, and various community-based organizations, with a focus on projects that demonstrate proof-of-concept and the development of working prototypes without integrating clinical trials. This initiative is crucial for fostering technological advancements that enhance understanding of biological processes, with no budget cap and a maximum project duration of five years. Interested applicants can find more information and application guidelines at NIH Grants, with proposals due by January 7, 2028.
    Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Opportunities for New and 'At-Risk' Investigators to Promote Workforce Diversity," aimed at enhancing diversity within the biomedical research workforce. This initiative invites R01 grant applications for independent research projects that align with the scientific missions of participating NIH Institutes or Centers, specifically targeting New Investigators and At-Risk Investigators from underrepresented backgrounds, including racial and ethnic minorities and individuals with disabilities. The program underscores the significance of diverse perspectives in addressing health disparities and aims to strengthen the research pipeline while fostering innovative solutions to public health challenges. Interested applicants can find more information and guidelines at the NIH grants website, with applications due by November 5, 2027. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) Program (RC2 - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the Sustainable Transformation of Institutional Research Rigor (STIRR) Program, a federal grant opportunity aimed at enhancing research rigor and transparency within academic and research institutions in the field of neuroscience. This initiative seeks to support innovative programs and strategies that promote high-quality research practices, emphasizing rigorous study design and transparent reporting to foster a culture of scientific integrity. The NIH plans to allocate approximately $3.5 million annually for up to five awards, with individual grants ranging from $150,000 to $800,000 over a three-year period. Interested applicants must submit their proposals by October 17, 2025, and can find additional information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), in collaboration with the Centers for Disease Control and Prevention (CDC), has announced the Innovation Corps (I-Corps) at NIH Program, aimed at enhancing the commercialization of biomedical innovations from Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase I projects. This program provides administrative supplement awards to eligible small business concerns, facilitating entrepreneurship training and assisting teams in refining their commercialization strategies through customer discovery activities over an eight-week course. With a total funding pool of up to $2.64 million available for up to 48 awards, individual grants are capped at $55,000, and applications must be submitted by January 31, 2025. Interested applicants are encouraged to contact NIH Grants Information at grantsinfo@nih.gov for further guidance before applying.